Abstract
Lactic acid bacteria (LABs) are being used as a probiotic very often for various enteric problems. Many genetically modified LABs are created by different workers for various novel applications. In this study we examine the expression of heterologous oxalate decarboxylase (oxdc) in Lactobacillus plantarum NC8. Generally, this enzyme is not present in Lactobacillus spp. Oxdc gene from Bacillus subtilis was polymerase chain reaction-amplified and cloned in a shuttle vector pSIP400 series, downstream of the inducible promoter, Porfx. In the presence of an inducing peptide, Sakacin-P, the expression of OxdC was observed in sodium dodecyl sulfate–polyacrylamide gel electrophoresis. The cell-free extract and the purified protein from the recombinant LABs showed the presence of OxdC activity. The above recombinant LABs, with desired modifications, can be used as a possible probiotic for the degradation of intestinal dietary oxalate for preventing enteric hyperoxaluria.
Similar content being viewed by others
References
Ahmed FE (2003) Genetically modified probiotics in food. Trends Biotechnol 21:491–497
Aukrust T, Blom H (1992) Transformation of Lactobacillus strains used in meat and vegetable fermentations. Food Res Int 25:253–261
Ausubel FM, Brent R, Kingston RE et al (eds) (1999) Short protocols in molecular biology. Wiley, New York
Campieri C, Campieri M, Bertuzzi V et al (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105
Clark JH, Fitzgerald JF, Bergstein JM (1985) Nephrolithiasis in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 4:829–834
FAO/ WHO (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Food Agriculture Organization of the United Nations and World Health Organization. Expert consultation Report. Available from www.who.int/food safety/publications/fs-management/en/probiotics.pdf
Hanniffy S, Wiedermann U, Repa A et al (2004) Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Micobiol 56:1–63
Harish K, Vargese T (2006) Probiotics in humans: evidence based review. Calicut Med J 4:e3
Hazebrouck S, Oozeer R, Adel-Patient K et al (2006) Constitutive delivery of bovine beta-lactoglobulin to the digestive tracts of gnotobiotic mice by engineered Lactobacillus casei. Appl Environ Microbiol 72:7460–7467
Hoppe B, Beck B, Gatter N et al (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1198–1200
Hylander E, Jarnun SS, Jensen HJ et al (1978) Enteric hyperoxaluria: dependence on small intestinal resection, colectomy, and steatorrhoea in chronic inflammatory bowel disease. Scand J Gastroenterol 13:577–588
Just VJ, Stevenson CEM, Bowater L et al (2004) A closed conformation of Bacillus subtilis oxalate decarboaylase OxdC provides evidence for the true identity of the active site. J Biol Chem 279:19867–19874
Kruger C, Hu Y, Pan Q et al (2002) In situ delivery of passive immunity by Lactobacillus producing single-chain antibodies. Nat Biotechnol 20:702–706
Mathews LA, Doershuk CF, Stern RC et al (1996) Urolithiasis and cystic fibrosis. J Urol 155:1563–1564
Marteu P, Seksik P, Jian R (2002) Probiotics and intestinal health: a clinical perspective. Br J Nutr 88:s51–s57
Niezielin K, Kordecki H, Birkenfeld B (2001) A controlled double-blind, randomized study on the efficacy of Lactobacillus plantarum 299 V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13:1143–1147
O’Sullivan DJ, Klaenhammer TR (1993) Rapid mini-prep isolation of high-quality plasmid DNA from Lactococcus and Lactobacillus spp. Appl Environ Microbiol 59:2730–2733
Pouwels PH, Vriesema A, Martinez B et al (2001) Lactobacilli as vehicles for targeting antigens to mucosal tissues by surface exposition of foreign antigens. Methods Enzymol 336:359–402
Prakash S, Martoni C (2006) Towards a new generation of bacterial cell therapy: artificial cells as a vehicle for safe and effective delivery of probiotics. Appl Biochem Biotechnol 128:1–21
Renault P (2002) Genetically modified Lactic acid bacteria: applications to food or health risk assessment. Biochime 84:1073–1087
Sambrook J, Russell D (eds) (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Sidhu H, Schmidt ME, Cornelius JG et al (1999) Direct correlation between hyperoxaluria, oxalate stone disease and the absebce of the gastrointestinal tract dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme therapy. J Am Soc Nephrol 10:S334–S340
Sidhu H, Allison MJ, Chow JM et al (2001) Rapid reversal of hyperoxaluria in a rat model following probiotic administration of Oxalobacter formigenes. J Urol 166:1487–1491
Sorvig E, Mathiesen G, Naterstad K et al (2005) High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors. Microbiology 151:2439–2446
Steidler L, Hans W, Schotte L et al (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352–1355
Steidler L, Neirynck S, Huyghebaert N et al (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin-10. Nat Biotechnol 21:785–789
Tanner A, Bornemann S (2000) Bacillus subtilis YvrK is an acid-induced oxalate decarboxylase. J Bacteriol 182:5271–5273
Tanner A, Bowater L, Fairhurst SA, Bornemann S (2001) High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors. J Biol Chem 276:43627–43634
Wells JM, Mercenier A (2003) Lactic acid bacteria as mucosal delivery vehicles. In: Wood BJ, Warner PJ (eds). Genetics of Lactic acid bacteria. Kluwer Academic/Plenum, New York, Vol III, pp 261–290
Acknowledgments
The first author acknowledges the Council for Scientific and Industrial Research (CSIR) for providing the senior research fellowship. The authors wish to thank Dr. Lars Axelsson for providing the plasmid pSIP409, induction peptide, and Lb.plantarum NC8. Further thanks to Dr. Stephen Bornemann for providing the plasmid pLB36 consisting oxdc gene.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kolandaswamy, A., George, L. & Sadasivam, S. Heterologous Expression of Oxalate Decarboxylase in Lactobacillus plantarum NC8. Curr Microbiol 58, 117–121 (2009). https://doi.org/10.1007/s00284-008-9286-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-008-9286-6